Research Topics
| A S GardenSummaryAffiliation: The University of Texas Country: USA Publications
| Collaborators
|
Detail Information
Publications
Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapyAdam S Garden
Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 85:941-7. 2013..To report mature results of a large cohort of patients diagnosed with squamous cell carcinoma of the oropharynx who were treated with intensity modulated radiation therapy (IMRT)...
Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st centuryAdam S Garden
Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Radiat Oncol 8:21. 2013..We performed this study to assess outcomes of patients with oropharyngeal cancer treated with modern therapy approaches...- Assessment of shoulder position variation and its impact on IMRT and VMAT doses for head and neck cancerEmily Neubauer
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Radiat Oncol 7:19. 2012..The purpose of this study was to determine the interfractional displacement of the shoulders relative to isocenter over the course of treatment and the associated dosimetric effect of this displacement... - Head and neck radiation and mucositisAdam S Garden
Departments of Radiation Oncology and Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Curr Opin Support Palliat Care 1:30-4. 2007..We will review the recent literature that has provided new insights into the pathogenesis, metrics and therapeutics of mucositis... 
Mucositis: current management and investigationsAdam S Garden
Department of Radiation Oncology, The University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
Semin Radiat Oncol 13:267-73. 2003....- Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?Adam S Garden
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
Int J Radiat Oncol Biol Phys 55:322-8. 2003..This retrospective study updated the results of RT for patients treated at our center. The primary focus of this study was whether a policy of using hyperfractionated RT for these patients resulted in a therapeutic gain... - Organ preservation for carcinoma of the larynx and hypopharynxA S Garden
Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Hematol Oncol Clin North Am 15:243-60, v. 2001..Both retrospective experiences and randomized trials evaluating differing therapies in an effort to achieve voice preservation are reported and analyzed... - Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?Adam S Garden
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 100:1171-8. 2004.... - Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neckA S Garden
Department of Radiation Oncology, Unit 97, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
J Clin Oncol 22:2856-64. 2004..To define further the role of concurrent chemoradiotherapy for patients with advanced squamous carcinoma of the head and neck... - How to reduce radiation-related toxicity in patients with cancer of the head and neckAdam S Garden
Department of Radiation Oncology and Head and Neck Surgery, The University of Texas M D Anderson Cancer Center, Houston TX, 77030, USA
Curr Oncol Rep 8:140-5. 2006..Minimizing radiation dose to these tissues may lower the incidence of radiation-induced dysphagia... - Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinomaAdam S Garden
Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 67:438-44. 2007.... - Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responsesA S Garden
Departments of Radiation Oncology, Thoracic Head and Neck Medical Oncology, and Head and Neck Surgery, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
J Clin Oncol 17:2390-5. 1999.... - A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003K K Fu
Department of Radiation Oncology, University of California San Francisco, 94143 0226, USA
Int J Radiat Oncol Biol Phys 48:7-16. 2000..The objective of this randomized trial was to test the efficacy of hyperfractionation and two types of accelerated fractionation individually against standard fractionation... - Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancerK K Ang
Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 51:571-8. 2001..These findings emphasize the importance of coordinated interdisciplinary care in the delivery of combined surgery and RT... - Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trialD M Shin
Departments of Thoracic Head and Neck Medical Oncology, Diagnostic Imaging, Head and Neck Surgery, Biostatistics, Radiation Oncology, and Clinical Cancer Prevention, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
J Clin Oncol 19:3010-7. 2001..We designed the present phase II adjuvant trial to prevent recurrence or second primary tumors (SPTs) using 13-cRA, IFN-alpha, and alpha-tocopherol in locally advanced-stage head and neck cancer... - Postoperative radiotherapy for malignant tumors of the submandibular glandM R Storey
Department of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA
Int J Radiat Oncol Biol Phys 51:952-8. 2001..In the current series, locoregional control rates for high-risk patients with submandibular gland cancers treated with surgery and postoperative radiotherapy were excellent, with an actuarial locoregional control rate of 88% at 10 years... - Can positron emission tomography improve the quality of care for head-and-neck cancer patients?N R Schechter
Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 51:4-9. 2001..The purpose of this review is to assess the potential contribution of FDG-PET scans to the treatment of head-and-neck cancer patients... - Sonographic examination of the neck after definitive radiotherapy for node-positive oropharyngeal cancerS S Yom
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, 77030, USA
AJNR Am J Neuroradiol 32:1532-8. 2011..The purpose of this study was to evaluate the utility of US, with or without FNA, in regard to the postradiotherapy effects on documented metastatic adenopathy in patients with oropharyngeal cancer... - Altered fractionation for head and neck cancerA S Garden
Department of Radiation Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston 77030, USA
Oncology (Williston Park) 15:1326-32, 1334; discussion 1334, 1339-41. 2001..This randomized trial of more than 1,000 patients addressed various fractionation schedules proposed to improve results for head and neck cancer patients treated with radiation... - Benign ulceration as a manifestation of soft tissue radiation necrosis: imaging findingsJ M Debnam
Department of Radiology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
AJNR Am J Neuroradiol 29:558-62. 2008..The purpose of this study was to review CT imaging findings of soft tissue mucosal ulceration in patients following radiation treatment for head and neck malignancies and to correlate these with patient outcomes... - Radiotherapy for head and neck cancerD L Schwartz
Department of Radiation Oncology, M D Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Hematol Oncol Clin North Am 20:259-85. 2006..Continued dedication and work on the part of provider and patient alike will be required to make this promise a reality... - TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology GroupAndy Trotti
H Lee Moffitt Cancer Center at the University of South Florida, Tampa, FL 33612 9497, USA
Lancet Oncol 8:613-24. 2007.... - Combination of radiotherapy with EGFR antagonists for head and neck carcinomaJuliette Thariat
Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Int J Clin Oncol 12:99-110. 2007.... - Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomiaMark S Chambers
Department of Head and Neck Surgery, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 69:1369-76. 2007..To assess the safety of long-term cevimeline treatment of radiation-induced xerostomia in patients with head-and-neck cancer; and to assess the efficacy of cevimeline in these patients... - Postoperative radiotherapy for maxillary sinus cancer: long-term outcomes and toxicities of treatmentIan J Bristol
Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 68:719-30. 2007..To determine the effects of three changes in radiotherapy technique on the outcomes for patients irradiated postoperatively for maxillary sinus cancer... - Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck moduleDavid I Rosenthal
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Head Neck 29:923-31. 2007.... - The effect of dental artifacts, contrast media, and experience on interobserver contouring variations in head and neck anatomyDavid I Rosenthal
Department of Radiation Physics, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Am J Clin Oncol 30:191-8. 2007..To investigate interobserver variability in the delineation of head-and-neck (H&N) anatomic structures on CT images, including the effects of image artifacts and observer experience... - The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancersMichael E Kupferman
Department of Head and Neck Surgery, University of Texas M D Anderson Cancer Center, Houston, Texas 77096, USA
Cancer 109:2052-7. 2007..To further explore its therapeutic benefit in the management of head and neck squamous cell carcinoma, the authors reviewed their experience utilizing IBT at the M. D. Anderson Cancer Center... - Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignanciesLinda S Elting
Section of Health Services Research, Department of Biostatistics, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 68:1110-20. 2007..To study the risk, outcomes, and costs of radiation-induced oral mucositis (OM) among patients receiving radiotherapy (RT) to head and neck primary cancers... - Intensity-modulated radiation therapy and xerostomiaMark S Chambers
Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA
J Calif Dent Assoc 34:743-8. 2006.... - Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14K Kian Ang
The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 97, Houston, TX 77030, USA
J Clin Oncol 23:3008-15. 2005..To investigate the feasibility of combining concomitant boost accelerated radiation regimen (AFX-C) with cisplatin and to assess its toxicity and the relapse pattern and survival in patients with advanced head and neck carcinoma (HNC)... - Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaireJoel B Epstein
Department of Oral Medicine and Diagnostic Sciences, College of Dentistry and Chicago Cancer Center, University of Illinois, Chicago, Illinois 60612, USA
Cancer 109:1914-22. 2007..The OMWQ-HN is a patient-reported outcome questionnaire that measures the symptoms of mucositis, including mouth and throat soreness (MTS), and their impact on patient well-being and function... - Outcomes after radiotherapy for squamous cell carcinoma of the eyelidJanjira Petsuksiri
Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 112:111-8. 2008..Squamous cell carcinoma (SCC) of the eyelid is a rare malignancy with metastatic potential. In the current study, the outcomes of patients with SCC of the eyelid were evaluated after definitive and postoperative radiation therapy... - Cerebrovascular disease risk in older head and neck cancer patients after radiotherapyGrace L Smith
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
J Clin Oncol 26:5119-25. 2008..Cerebrovascular disease is common in head and neck cancer patients, but it is unknown whether radiotherapy increases the cerebrovascular disease risk in this population... - Performance evaluation of automatic anatomy segmentation algorithm on repeat or four-dimensional computed tomography images using deformable image registration methodHe Wang
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
Int J Radiat Oncol Biol Phys 72:210-9. 2008..The goal of this study was to quantitatively evaluate the performance of the algorithm in typical clinical applications... - Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formationMark S Chambers
Department of Head and Neck Surgery, Department of Radiation Oncology, M D Anderson Cancer Center, Houston, TX 77030 4009, USA
J Prosthet Dent 100:142-6. 2008..Determining the impact that salivary sediments have on measured salivary flow rates during radiation is important for management of patients... - Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14)Adam S Garden
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 71:1351-5. 2008..This article reports the long-term toxicity, relapse patterns, and survival in patients with advanced head and neck carcinoma... - Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysisMitchell Machtay
Jefferson Medical College and Kimmel Cancer Center of Thomas Jefferson University, Philadelphia, PA, USA
J Clin Oncol 26:3582-9. 2008..This study evaluates clinical factors that are associated with and might predict severe late toxicity after CCRT... - Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control studyJuliette Thariat
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 112:2698-709. 2008..Its poorer prognosis compared with common SCC remains controversial. The authors investigated the outcomes of patients with BSCC who received radiotherapy and compared them with the outcomes of patients with SCC... - Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern eraDavid L Schwartz
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Head Neck 30:883-8. 2008..The purpose of this study is to catalog modern-era postoperative radiotherapy (external beam radiotherapy [EBRT]) outcomes for advanced medullary thyroid cancer... - Long-term radiotherapy outcomes for nasal cavity and septal cancersMatthew W Allen
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 71:401-6. 2008..Carcinoma of the nasal cavity and septum has historically been associated with a poor prognosis. This report updates the long-term outcomes for radiotherapy (RT) of this disease site at the University of Texas M.D. Anderson Cancer Center... - Psychosocial and economic impact of cancerLinda S Elting
Section of Health Services Research, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 447, Houston, TX 77030, USA
Dent Clin North Am 52:231-52, x. 2008.... - Erratum to "Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 2: Phase I study"Mark S Chambers
Department of Head and Neck Surgery, Department of Radiation Oncology, M D Anderson Cancer Center, Houston, TX 77030, USA
Oral Oncol 43:98-105. 2007..It would be more convenient than the daily home application of a tray of 0.4% stannous fluoride or 1.1% sodium fluoride gel, and avoids the problem of variable patient compliance... - Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get?Jennifer C O'Daniel
Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 69:1290-6. 2007..To quantify the differences between planned and delivered parotid gland and target doses, and to assess the benefits of daily bone alignment for head and neck cancer patients treated with intensity-modulated radiotherapy (IMRT)... - Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysisFarzan Siddiqui
Department of Radiation Oncology, Henry Ford Health System, Detroit, MI 48202, USA
Int J Radiat Oncol Biol Phys 70:353-60. 2008.... - Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neckAnne S Tsao
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA
J Clin Oncol 24:4163-9. 2006..Phase III trials are needed to assess the contribution of concomitant boost fractionation to chemoradiotherapy... - Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 1: FluoridesMark S Chambers
Department of Head and Neck Surgery, Department of Radiation Oncology, M D Anderson Cancer Center, Houston, TX 77030, USA
Oral Oncol 42:934-45. 2006..Part 1 discusses the historical and currently available fluoride preparations and Part 2 presents data of a recently completed trial investigating the benefit of an intraoral sodium fluoride releasing system... - Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and managementMark S Chambers
Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA
Head Neck 26:796-807. 2004..Xerostomia is a common, debilitating complication of radiation therapy (RT) for head and neck cancer. This article reviews the pathogenesis of radiation-induced xerostomia, its impact on quality of life (QOL), and treatment options... - Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator systemJerry L Barker
Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 59:960-70. 2004..In theory, such a strategy would maximize the therapeutic ratio of RT... - New equations for matching a low neck field to oblique upper neck fields with collimator rotation in a 3-field monoisocentric setup for head-and-neck cancersMaria A Manske
Department of Radiation Physics, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Med Dosim 29:86-91. 2004..They predict the necessary manipulations of the LAN boost field to maintain a geometrically precise matchline, as verified by 3D treatment planning software, phantom dosimetry, and actual patient setups... - Radiation therapy for early-stage carcinoma of the oropharynxUgur Selek
Department of Radiation Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, 77030, USA
Int J Radiat Oncol Biol Phys 59:743-51. 2004..The development of second primary tumors of the UADT adversely impacts survival in these patients to as great a degree as the index cancer... - Target coverage for head and neck cancers treated with IMRT: review of clinical experiencesAdam S Garden
Department of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
Semin Radiat Oncol 14:103-9. 2004..This review will focus on how IMRT is being implemented into the treatment of head and neck cancer, specifically with regards to target definition and dosing issues... - Risk of osteoradionecrosis after extraction of impacted third molars in irradiated head and neck cancer patientsHee Kyun Oh
Department of Oral and Maxillofacial Surgery, College of Dentistry, Chonnam National University, South Korea
J Oral Maxillofac Surg 62:139-44. 2004..This study was performed to compare the risk of osteoradionecrosis (ORN) in head and neck cancer patients in whom 1 or more impacted third molars were extracted before radiotherapy with patients whose impacted third molars were left intact... - Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neckMark D Bonnen
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Cancer 100:383-9. 2004..It may also serve as an alternative to sentinel lymph node biopsy, particularly for patients for whom dissection and systemic therapy are not therapeutic options... - Where are the at-risk cervical nodes?Adam S Garden
Int J Radiat Oncol Biol Phys 58:1-2. 2004 - Management of nonsinonasal neuroendocrine carcinomas of the head and neckJerry L Barker
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 98:2322-8. 2003.... - Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinomaVassiliki A Papadimitrakopoulou
Department of Thoracic Head and Neck Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 98:2214-23. 2003.... - Adjuvant irradiation for cervical lymph node metastases from melanomaMatthew T Ballo
Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas77030, USA
Cancer 97:1789-96. 2003..The risk of regional disease recurrence after surgery alone for lymph node metastases from melanoma is well documented. The role of adjuvant irradiation remains controversial... - Adult rhabdomyosarcoma: outcome following multimodality treatmentDarren J Little
Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 95:377-88. 2002..Local control is satisfactory for sites other than parameningeal where new radiation technologies such as intensity-modulated therapy may be necessary to safely deliver adequate doses... - Electron conformal radiotherapy using bolus and intensity modulationRajat J Kudchadker
Department of Radiation Physics, M D Anderson Cancer Center, University of Texas, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 53:1023-37. 2002..The present work evaluates the ability to restore dose homogeneity by varying the incident electron intensity... - Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotypeDavid I Rosenthal
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Cancer 101:2567-73. 2004..The authors reviewed their institutional experience to determine whether sinonasal neuroendocrine tumors of different histologies have distinct clinical characteristics that warrant individualized treatment approaches... - Is there still a role for induction chemotherapy for head and neck cancer?Adam S Garden
J Clin Oncol 23:1059-60. 2005 - Two-field versus three-field irradiation technique in the postoperative treatment of head-and-neck cancerSue S Yom
Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 66:469-76. 2006..Despite its use in more challenging cases, CTT provides similar long-term clinical outcomes compared with standard 3FT, when computerized three-dimensional dosimetry is used to assure adequate dosimetry throughout the treated volume... - Importance of patient examination to clinical quality assurance in head and neck radiation oncologyDavid I Rosenthal
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Head Neck 28:967-73. 2006..We determined the value of clinical peer review in radiation therapy for head and neck cancer that involved head and neck examination... - Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 2: Phase I studyMark S Chambers
Department of Head and Neck Surgery, Department of Radiation Oncology, M D Anderson Cancer Center, Houston, TX 77030, USA
Oral Oncol 42:946-53. 2006..It would be more convenient than the daily home application of a tray of 0.4% stannous fluoride or 1.1% sodium fluoride gel, and avoids the problem of variable patient compliance... - Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13Elizabeth A Elliott
Juravinski Cancer Centre at Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
J Clin Oncol 24:2092-7. 2006..This multicentered phase III trial was designed to compare an emulsion containing trolamine against the usual supportive care within each participating institution for patients with head and neck cancer undergoing radiation therapy... - Impact of changes to the American Joint Committee on Cancer T classification on outcome prediction in patients with oropharyngeal cancerJoshua A Asper
Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 106:1950-7. 2006..CONCLUSIONS: The modifications established in the 6th edition of the AJCC tumor staging system for oropharyngeal tumors appear to be useful to distinguish prognostic groups for both LC and OS based on tumor stage... - Multiple regions-of-interest analysis of setup uncertainties for head-and-neck cancer radiotherapyLifei Zhang
Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 64:1559-69. 2006..CONCLUSIONS: We found variability in setup corrections for different regions of head-and-neck anatomy. These relative positional variations should be considered when making setup corrections or designing treatment margins... - Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodesSmith Apisarnthanarax
Department of Experimental Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 64:678-83. 2006.... - Selective vs modified radical neck dissection and postoperative radiotherapy vs observation in the treatment of squamous cell carcinoma of the oral tongueBradley A Schiff
Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston 77030-4009, USA
Arch Otolaryngol Head Neck Surg 131:874-8. 2005..Prospective, randomized clinical trials will be useful in further defining the role of selective neck dissection in the clinically N2 neck and radiotherapy in the N1 neck for patients with SCC of the oral tongue... - A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinomaFaye M Johnson
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 63:717-24. 2005..Local recurrence remains the major reason for treatment failure in advanced T-stage NPC, especially WHO types 1 and 2. Other strategies to improve local control in these patients should be investigated... - Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease?Matthew T Ballo
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Head Neck 27:718-21. 2005..Completion cervical lymphadenectomy is usually performed after excisional biopsy of nodal metastases from melanoma. Radiation (XRT) might be effective for some patients in lieu of formal lymph node dissection... - Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variantsDavid G Kornguth
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
Int J Radiat Oncol Biol Phys 62:665-71. 2005..We hypothesized that two ERCC4 single-nucleotide polymorphisms are associated with normal-tissue toxicity in patients treated with radiotherapy for oropharyngeal squamous cell carcinoma (OPSCC)... - Intensity-modulated radiotherapy: is xerostomia still prevalent?Mark S Chambers
Department of Head and Neck Surgery, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030 4009, USA
Curr Oncol Rep 7:131-6. 2005.... - A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinomaVincent Gregoire
Department of Radiation Oncology, Universite Catholique de Louvain, St Luc University Hospital, 10 Avenue Hippocrate, Brussels, Belgium
Radiother Oncol 63:187-93. 2002..D. Anderson Cancer Center in Houston, and the other conducted in two Belgian hospitals) exploring concurrent fludarabine and radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinomas (HNSCC)... - Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapyHe Wang
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Phys Med Biol 50:2887-905. 2005..Together, these results suggest that the accelerated demons algorithm has significant potential for delineating and tracking doses in targets and critical structures during CT-guided radiotherapy...